 <h1>Lesinurad Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of lesinurad include:</b> increased serum creatinine. <b>Other side effects include:</b> acute kidney injury.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to lesinurad: oral tablets</i></p><h3>Warning</h3><p><ul>
<li>
Acute renal failure reported; more common when lesinurad administered as monotherapy.&lt;sup&gt;1&lt;/sup&gt;  Use lesinurad in combination with a xanthine oxidase inhibitor (e.g., allopurinol, febuxostat).&lt;sup&gt;1&lt;/sup&gt;  (See Renal Effects under Cautions.)</li></ul></p><ul>
<li>
Acute renal failure reported; more common when lesinurad administered as monotherapy.&lt;sup&gt;1&lt;/sup&gt;  Use lesinurad in combination with a xanthine oxidase inhibitor (e.g., allopurinol, febuxostat).&lt;sup&gt;1&lt;/sup&gt;  (See Renal Effects under Cautions.)</li></ul><p></p><p>Side effects include:</p><p>Headache,   influenza,  increased S<sub>cr</sub>,   GERD. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lesinurad: oral tablet</i></p><h3>General</h3><p>The more common side effects include increased serum creatinine, headache, influenza, and gastroesophageal reflux disease.<sup>[Ref]</sup></p><h3>Renal</h3><p>When used at labeled doses in combination with a xanthine oxidase inhibitor (XOI), serum creatinine increases of 1.5 to less than 2 times or 2 times or greater from baseline occurred in 3.9% (n=20/511) and 1.8% (n=9/511) of patients, respectively.  Increased serum creatinine levels resolved in most patients (up to 90%) without treatment interruption.  Based on baseline renal function, serum creatinine increases occurred in 3%, 3.8%, and 6.9% of patients with normal (CrCl greater than 90 mL/min), mild (CrCl 60 to less than 90 mL/min), or moderate (CrCl greater than 30 to less than 60 mL/min) renal impairment.</p><p></p><p>Use at higher than approved doses with or without an XOI resulted in increased serum creatinine levels.  Consistently, patients receiving 400 mg daily as monotherapy experienced a higher incidence of renal failure.  Nephrolithiasis occurred more frequently in patients receiving 400 mg daily in combination with an XOI (2.5%) compared to labeled doses in combination with an XOI (0.6%).<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Increased serum creatinine, renal failure</p><p><b>Uncommon</b> (0.1% to 1%): Nephrolithiasis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastroesophageal reflux disease<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Cardiovascular death, non-fatal myocardial infarction, non-fatal stroke<sup>[Ref]</sup></p><p>Incidence rate ratios for major adverse cardiac events compared to placebo were 1.36 (95% CI: 0.23, 9.25) in 200 mg and 2.71 (95% CI: 0.66, 16) in 400 mg.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Zurampic (lesinurad)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><h2>More about lesinurad</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: antihyperuricemic agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lesinurad &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Gout</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>